Rational design, synthesis, and anticancer evaluation of amide derivatives of Pyridin3-yl)imidazo[2,1-b][1,3,4]thiadiazole linked 1,3,4-oxadiazoles

A new series of amides of pyridin-3-yl)imidazo[2,1-b][1,3,4]thiadiazoles (13a-j) have been developed and confirmed by 1HNMR, 13CNMR and mass spectral data. Further, in the vitro anticancer activity of newly prepared compounds 13a-j was examined against four human cancer cell lines including MCF-7 &a...

Full description

Saved in:
Bibliographic Details
Published in:Chemical Data Collections 2024-08, Vol.52, p.101147, Article 101147
Main Authors: Shaik, Khasim Saheb, N, Saritha, G, Nagendra Reddy
Format: Article
Language:English
Subjects:
Anticancer properties
Crizotinib
Human cancer cell lines
Pyridineand
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A new series of amides of pyridin-3-yl)imidazo[2,1-b][1,3,4]thiadiazoles (13a-j) have been developed and confirmed by 1HNMR, 13CNMR and mass spectral data. Further, in the vitro anticancer activity of newly prepared compounds 13a-j was examined against four human cancer cell lines including MCF-7 & MDA MB-231 (human breast cancer), A549 (human lung cancer) and DU-145 (human prostate cancer) by employing the MTT assay, and using etoposide as a standard reference. These results indicated that the most of the derivatives displayed excellent to moderate anticancer activity. Among the five compounds 13a, 13b, 13c, 13d and 13e demonstrated remarkable activity as standard. One of the compounds 13a displayed excellent activity. [Display omitted]
ISSN:2405-8300
2405-8300
DOI:10.1016/j.cdc.2024.101147